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The mechanism of the therapeutic and prophylactic effects of carbamazepine (CBZ) in affective psychose.s is unknown but may 
in part be related to the potent competitive interaction of CBZ with adenosine-binding sites in the brain. The antioonvuls4l:At and 
sedative properties of CBZ are reminiscent of the effects evoked by adenosine-agonists and contrast sharply with the opposite 
aclions of adenosine-antagonists like caffeine. However. indirect evidence suggests an antagonist- rather than an agonist-like 
activity of CBZ at adenosi11e-receptors. We have used various model systems, in which adenosine receptor subtypes mediate 
different second messenger-responses, to investigate this apparent paradox. CBZ was found to antagonize the Ai·ret:eptor-media-
ted inhibition of cydic AMP accumulation in cultured astroblasts and in GH3-cells. Furthermore, CBZ also inh.ibits the 
adenosi.ne-induced increase in the Ievel of cyclic ".MP in cultured astrobla.sts, which is med.iated by low-affinity A 2b-receptors. ln 
contrast, CBZ does not block the inhibition elicited by adenosine-agonists of the agonist-induced increased formation of 
inositolphosphates in human neutrophils, which is mediated by high-affinity A 23-receptors. The specific antagonism by CBZ of A 1-
but not of high-affinity A 23-receptors was further supported by binding experiments using rat brain membranes. These results 
suggest tbat the paradox of CBZ's antagonistic effects at adenosine-receptors might be at least partially reconciled by a selective 
anta%onistic action of CBZ at A 1recertors but not at high-affinity A2a-receptors. 
Adenosine receptors; Cyclic AMP; Inositol phosphates: Astroglia; GH 3-ce1ls; Neutrophils {human) 
t. lntroduction 
The tricyclic iminostilbene-derivative carbarnazepine 
(CBZ) is weil known for its anticonvulsive properties 
and its efficacy in the treatment of paroJ(ysrnal pain 
syndromes. Over the last few years evidence has accu-
mulated that CBZ is also effective in the treatment of 
acute mania and as a prophylactic agent in manic-de-
pressive illness (for recent reviews see Elphick. 1988; 
Post, 1987, 1990; Schmidt and Greif, 1987). The anti-
convulsive properties of CBZ may predominantly be 
due to allosteric blockade of voltage-sensitive Na~· 
cbanne)s (for review see Catteral, 1987), while GABA 8 
mechanisms may account for its antinociceptive proper-
lies (for review see Post. 1990). Among the various other 
potential mechanisms that may be responsible for CBZ's 
efficacy in affective psychoses (for review see Elphick. 
1988; Post, 1987, 1990) its interaction with adenosine 
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binding sites in the brain has received special attention 
(Fujiwara et al.. 1987: Gasser et al., 1988; Marangos et 
al.. 1985, 1987a.b,c~ Plüllis. 1984: Skerritt et al., 1983a, 
b; Weir et al.. 1984). The clinical properties of CBZ are 
reminiscent of the anticonvulsive. sedative and anxio-
1ytic effects of adenosine-agonists and cantrast sharply 
to the opposite actions of adenosine-antagonists like 
caffeine ( for review see Bridges et al.. 1988). Although 
this would suggest that CBZ might have adenosine-
agonist properties, there is substantial indirect evidence 
to the contrary. Chronic administration of CBZ to rats, 
like that of caffeine, results in persistent up-regulation 
of adenosine binding sites in the brain (Daval et al., 
1989; Marangos et al., 1985, 1987b)_ In additio~ CBZ's 
effects on adenosine bi.nding sites are affected by tem-
perature and guanyl nucleotides in a manner typical for 
adenosine antagonists (Marangos et aL. 1987b ). 
Possible mixed agonist~antagonist properties of CBZ 
andjor differential effects on adenosine receptor sub-
types have been suggested to account for thls parado;:: 
(Post, 1987). Adenosine receplors have been originally 
distinguished as A 1-receptors t~t inhibtt and A2-recep-
tors thal activate adenylate cyclase (Londos et al .• 1980; 
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Van Calker et al., 1978, 1979). Based on ·more recent 
evidence indicating that adenosine receptor-reguJated 
events might in several cases also be independent of 
cyclic AMP. adenosine receptors are now classified 
according to the structure-activity-reJationship (SAR) of 
various adcnosine analogues (Hamprecht and Van 
Calker, 1985). In addition, A2-receptors could be fur~ 
ther subdivided into high-affinity A 211·receptors and 
Iow-affinity A 2b-receptors, which apparently also shuw 
differences in the SAR of newly deveJoped adenosine~ 
analogues (Bruns et al., 1987). 
To assess directly the question of possible agonist or 
antagonist actions of CBZ at adenosine receptor sub-
types, we have investigated the effects of CBZ in cellu-
lar model systems. in which adenosine receptor sub-
typesmediate different second messenger-responses. The 
results indicate that CBZ antagonizes the effects of 
adenosine at A 1-receptors but not at A .::a·receptors. 
2. Materials and methods 
2.1. Materials 
Eagle's basal medium (with Earle's salts) without 
inositoJ was prepared by Serva, all other cell culture 
media and sera were obtained from Boehringer, Mann-
heim. Myo-( 3H)inositol (with PT6-271) was from 
Amersham, Ficoll-Hypaque from Pharmacia. 2-Chloro-
N6 -[ 3 HJcyclopentyladenosine ([ 3 H]CCP A) was obtained 
from NEN, 8-cyclopentyl-1 ,3-[ 3 H]dipropylxanthine 
([ 3H]DPCPX) from Amersham. All other chemieals were 
from Sigma. 
2.2. Cell cu/ture 
GH~-cells were a gift from Dr. B. Hamprecht. Physi-
ologisch-Chemisches Institut, Tubingen, F.R.G. They 
were cultivated in Ham's F 10 medium (Boehringer, 
Mannheim) containing 2.5% fetal calf serum and 15% 
horse serum (Boehringer) in plastic tissue culture flasks 
(Falcon or Costar) in a humidified atmosphere (5% 
C02 ) at 37°C. The medium was changed two to three 
tirnes a week, depending on the ceJJ density and the cells 
were subcultivated every 1-2 weeks. Cells were detached 
by vigorous pipetting, plated on tissue culture dishes 60 
mm in diameter (Nunc) and grown to a cell density of 
1-3 million cells per dish. 
Astrohlast cultures were prepared by mechanical dis-
sociation of newborn mouse or rat brain and cultivated 
as described previously (Van Calker et al., 1979). 
2.3. Isolation of neutrophils 
Human neutrophils were isolated from heparinized 
whole blood obtained from healthy volunteers by means 
of sedimentation through dextran (0. 6% w jv) followed 
by centrifugation through Ficoii-Hypaque and hypo-
tonic Iysis of contaminating erythrocytes (Dougherty et 
al.. 1984; Boyum, 1984). 
2.4. Measurement of inositol plzosphate production 
Washed neutrophils ~re suspended (50 million cells 
per ml) in Eagle's basal medium (with Earle's salts) 
without inositol containing deoxyribonuclease (50 
Ujm)) • fetal calf serum (3%) and 50 JLCi eH)inositol 
per ml and incubated at 37°C for 4-5 h in a shaking 
water bath. Thereafter cells were centrifuged, and 
washed two times with ice-cold Hank's balanced salt 
solution (HBSS) containing 20 mM N-2-hydroxyethyl-
piperazine-N'-2-ethansulfonic acid (HEPES), pH 7.4. 6 
million cells were then incubated with HBSS at 37°C in 
the presence of cytochalasin B (5 ~-tM), KCN (1 mM), 
LiCJ (10 mM) and other additions as required in a final 
volume of 1 ml. Controls received the corresponding 
amount of vehicle ( dimethylsulphoxide, final concentr.l· 
tion 0.05% ). The incubations were terminated at tbe 
desired times by addition of 1 ml ice-cold trichloro-
acetic acid (20% w jv). The samples were centrifuged 
and the pellet was washed once with distilled water. The 
combined supernatants were extracted with diethylether 
and fractionated by anion exchange chromatography on 
small Dowex columns as described previously (Van 
Calker et al., 1987). 
Cultured GH3-cells and astroblasts were labeled with 
[ 3H]inositol, stimulated with drugs and analyzed for the 
formation of eH]inositol phosphates essentially as de-
scribed previously for PC-12 cells (Van Calker et al., 
1987). 
2.5. Determination of cyclic AMP 
Dishes containing GH3-cells or astroblasts were 
washed twice with incubation buffer (118 mM NaCI, 4.7 
mM KCl, 3 mM CaCI, 1.2 mM MgCI, 1.2 mM KH2P04, 
0.5 mM EDTA, 10 mM glucose and 20 mM HEPES, 
pH 7.4) and thereafter incubated at 37°C for 10 min 
with 2 ml of the same buffer containing the various 
additions. Controls received the same amount of vehicle 
(dimethylsulfoxide, final concentrati0n 0.05%). Thein-
cubations were terminated by removal of the buffer and 
the addition of 1 ml ice-coJd trichloroacetic acid (10% 
w jv). After removal of the trichloroacetic acid by ex-
traction with diethyl ether (3 times 4 ml), the samples 
were fractionated by anion chromatography on small 
Dowex columns (Bio Rad AG 1 X 2) as described (Van 
Calker et al., 1979). The cyclic AMP content in the 
samples was determined by a commercially available 
protein binding assay (Amersham). 
2. 6. Radioligand binding 
Membranes from whole rat brain and rat striatum 
were prepared as described previously (Lohse et al., 
1987). Binding of [3H)5' N-ethylcarboxamido-adenosine 
(eHJNECA) (10 nM) in the presence of N 6-cyclopen-
tyiadenosine (CPA) (50 nM) to striatal membranes was 
performed according to Bruns et al. (1986) with the 
modifications described earlier (Lohse et al.. 1987). Bin-
ding assays using [3H]CCPA and [3H]DPCPX were 
done as described previously (Lohse et al., 1987; Klotz 
et al., 1989). 
3. Results 
3.1. Effects of carbamazepine on adenosine Arreceptors 
Adenosine inhibits via A1-receptors the increase in 
the accumulation of cyclic AMP. which is evoked in 
GH 3-cells ·by Stimulation with vasoactive intestinal 
peptide (VIP) (Delahunty et al., 1988) (fig. 1). CBZ (50 
ILM) alone slightJy reduces the VIP-induced stimulation 
of the accumulation of cyclic AMP (see legend to fig. 1). 
However, the most prominent effect of CBZ is a parallel 
shift to the right of the dose-respons: curve for the 
inhibitory action of adenosine (fig. 1 ). Similarly, also 
the A 1-receptor-mediated inhibition of the ß-adrenocep-
tor-jnduced increased formation of cycJic AMP in cuJ-
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Fig. 1. Innuence of carbamazepme {.JO ~M) on lhe inhibitie>n by 
adenosine of the VIP-evoked incrase in the leveJ of cyclic AMP in 
GH3-cells. Cells (1.6 million .,er dish) were incubated for 10 min in 
the presence of carbar!:.aepine or vehicle (dimethylsulfoxide. final 
concentration 0.05%J and the various other additions. The cydic AMP 
fonnd was ;o..;;sayed as described in Materials and methods. Controls 
(pmol cydic AMP per rnillion cells): basal, 1.0; VIP (0.1 pM). 101 ± 8 
( =WO%); VIP+ carbamazepine, 84 ± 7 ( = 100% ). Data given are 
means of triplicate determinations ± SD. SD's smaller than the size of 
the symbol are not shown. • P < 0.05, • * P < 0.01 (Student's t-test as 
compared to values without carbamazepine). Similar results were 
obtained in two additional independent experiments. 
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Fig. 2. InOuence of carbamazepine (50 pM) on the increas~ in the 
Ievel or cyclic A~AP e"·oked by adenosine in cultured astroglia cells. 
Cells were obtained by mechanical diss.x:iation of newbom rat l>rain 
and cultivated for 16 days as described previously (Van Calker ~t a1.. 
1979). They were th"'l incubated for 10 min with carbamazepine or 
vehkle, before the hlracellulac content of cyclic AMP was detenr,ined 
as uescribed in Materialsand methods. • P < 0.01. Other deta'~s are 
as in fig. l. Similar results were obtained in two additional indepen-
dent experiments. 
tured astroglia cells (Van CaJker et al., 1978, 1979) is 
antagonized by CBZ (data not shown). 
3.2. Effects of carbamazepine on (/ow-affinity) adenosine 
A 1b-receptors 
Adenosine and its analogues stimulate via adenosine 
A2-receptors the accumulation of cyclic AMP in primary 
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Fig. 3. Influence of carbamaz.epine ,:;o 1.1Ml on the inhibition by 
NECA of the fMLP-stimulated increase in the ae<.-umulation of in-
ositol phospbates in human neutro!)hils. Nc:utrophils were isolated 
and stimuJated with fMLP in the presence of carbamazepine or 
vehicle and various concentrations of NECA as descnl>P.d in Materials 
and methods. Similar results were obtained in two additional indepen-
dent experiments. 
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cultures of perinatal rodent brain, mainly consisting of 
astroglia cells (V an Calker et al., 1979). The l0w-affinity 
A 2-receptors that mediate this effect resemble those 
which have been calJed A:u .. (Bruns et al., 1987) and are 
found in virtually all grey matter areas of the brain 
(Daly et aJ.. 1983). CBZ attenuates the incrcase in the 
JevcJ of cydic AMP e·voked by adenosine in tl.e astro-
glia-rich cultures (fig. 2). 
3.3. Ef!ects of carbuma:epine 011 the udenosine A .'a -recep-
tor-meaiated inhibition of inositol phosphare formation in 
human neutrophils 
In human neutrophils adenosine and its analogues 
elicit only a minimal increase in the Ievel of cyclic AMP 
but provoke a pronounced inhibition of the agonist-in-
duced accumulc~tion of inositoJ phosphates. which is 
indeper.dent of cyclic AMP (Van Calker and Steber, 
submitted). This effecf is mediated via high-affinity 
adenosine A2-receptors (Van Calker and Steber. sub-
mitted). which resemble those found e.g. in the striatum 
and called •A 2a' (Bruns et aL 1987). In contrast to its 
effects on A 1- and A 20-receptors, CBZ does not at-
tenuate this effect but induces. if anything, rather a 
slight potentiation of the inhi'>ition evoked by the 
adenosine-agonist 5 '~N -ethylcarboxamidoadenosine 
(NECA) (fig. 3). 
3.4. Elfecrs of carbamazepine on the binding of radio-
/abeled A 1- and A 1 -ligands at rat brain rn~mbranes 
To further analyze the effects of CBZ at adenosine 
receptor subtypes we measured its interaction wlth A 1-
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Fig. 4. lniluence of carbamazepine on the binding of the radioligands 
eHJCCPA and eHJDPCPX to A1-sites in rat brain membranes and 
oC eHJNECA in the presence of CPA to A 2-sites in rat striatal 
membranes. Similar resuhs we:e obtained in two additional indepen· 
dent experiments. 
receptors in binding assays with membranes from rat 
brain performed with the highly A 1-selective radio-
ligands 2-ch loro-N 6 -[ 3 H ]cyclopentyladenosine 
<('H)CCPA, an agonist) (Klotz et al., 1989) and 8-
cyclopentyl-1.3-[3H]dipropylxanthine ([ 3 H]DPCPX, an 
antagonist) (Lohse et al.. 1987). The action of CBZ at 
high affini ty A za -receptors was evaluated with mem-
branes from rat striatum, using [3H}NECA as a radio-
ligand in the presence of N 6-cyclopentyladenosine 
(CPA) to block the binding to A1-sites (Bruns et al., 
1986). CßZ inhibited the binding of both [3H]CCPA 
and [3H]DPCPX to rat brain membranes (fig. 4). The 
displacement by CBZ of eHJDPCPX-binding was not 
influenced by the presence of 100 p.M GTP. In contrast, 
CBZ did not affect at concentrations below 100 p.M the 
binding of [3H)NECA to striatal membranes (fig. 4). 
4. Discussion 
The inhibitory effects of CBZ on adenosine-evoked 
second-messenger responses that are reported in the 
present study provide the first direct evidence that CBZ 
inhibits second messenger-responses mediated by 
adenosine A 1-receptors but not those mediated by 
high-affinity A 2a-receptors. CBZ induces a parallel shift 
to the right of the dose-response curve for the A 1-in-
duced inhibition of tbe VIP-stimulated cyclic AMP 
accumulation in GH3 -cells (fig. 1), as expected for a 
competitive interaction. In contrast, the A2a-mediated 
inhibition of the fMLP-stimulated formation of inositol 
phosphates in human ncutrophils is not antagonized by 
CBZ (fig. 3). 
In addition to its antagonistic effect at A 1-receptors 
CBZ also inhibits the A 2b-receptor-mediated increase in 
cyclic AMP in cultured astroglia cells (fig. 2). Similarly, 
CBZ at high concentrations also attenuates the adeno-
sine-evoked increase in the Ievel of cyclic AMP in brain 
slices (Lewin and Bleck, 1977; Skenitt et al., 1983a; 
Weir et al., 1984), which is probably also mediated by 
low-affinity A 2b-receptors (Daly et al., 1983). These 
effects may be at Jeast partially due to ~:-. antagonism of 
CBZ also at A 2b-receptors. However, the dose-response 
curve depicted in fig. 2 is not typical for a competitive 
interaction of CBZ with A2b-receptors. Furthennore, by 
mechanisms other than competitive inhibition, CBZ also 
weakly attenuates the increase in the Ievel of cyclic 
AMP evoked by the activation of putaüve A 2a-receptors 
in PC12 cells and platelets (Daly et al., 1988). Thus, 
mechanisms other than competitive inhibition could 
also account for thc inbibition by CBZ of cyclic AMP 
acoJmulation in various tissues and cell·types. A more 
detailed analysis of the mechanism of CBZ's inhibition 
of the adenosine-induced increase in cyclic AMP in 
astroblasts is hampered by the low affinity of the A 2b· 
receptors. 
A selective interaction of CBZ with A1-, but not 
A 23-receptors was further supported by binding studies 
using [3H]CCPA and [3H]DPCPX as highly selective 
A1-radioligands and [3H]NECA in the presence of CPA 
as A 23-radiolig~nd (fig. 4). While the present work was 
in progress, similar conclusions have been drawn from 
binding studies performed with Nr>-cyclohexyl-
[3H]adenosine and [3H]NECA (Clark and Post, 1989). 
CBZ's selective antagonism at A1-receptors may ex-
plain why its profile of clinical and behavioral effects is 
different from that of non-selP.ctive adenosine-
antagonists like theophylline and caffeine. Indeed, 8-
cyclopentyltheophylline (CPT). which acts as a selective 
A 1-antagonist in vivo, does not have the stimulating 
effect on locomotor activity which occurs with theophyl-
line. On the other hand, CPT has proconvulsant proper-
lies in animal models (for review see Bridges et al., 
1988). Thus, CBZ's A1-antagonistic properties are prob-
ably not involved in its anticonvulsant action, as al-
ready concluded from other evidence (Post, 1987). 
Although apparently not involved in its anti(.;vlH·-ül-
sive effects, the blockade of Acreceptors by CBZ might 
be related to its efficacy as a prophylactic, antimanic 
and possibly also antidepressive agent in affective 
psychoses. Several A1-antagonists show antidepressant-
Iike activities in animal models (see Bridge:; et al., 1988 
for review). In addition, effe~tive antidep; essive treat-
ments like electroconvulsive shock (Newma:: et al., 1984; 
Gleiter et al., 1989) and REM sleep depri\·ation (Y anik 
and Radulovacki, 198'7~ !!p-regulate A1-receptors, simi-
lar to chronic treatment with CBZ (Marangos et al., 
1985, 1987b; Daval et al., 1989). 
s~me of CBZ's compJex effects on various neuro-
transmitter systems seen in behavioral and biochemical 
studies (for review see Elphick. 1988; Post, 1987, 1990) 
could be indirectly mediated by the A 1-antagonistic 
action of CBZ, since the release of many excitatory and 
inhibitory neurotransmitters is inhibited by adenosine 
via A 1~receptors (for review see Bridgeset aJ., 1988). 
The use of CBZ as an :.lternative to Iithium in the 
treatment of manic~depressive iJiness raises the question 
of whether or not there are also similarities in the 
biochemical effects of both drugs. The inhibitory effects 
of chronic Iithium treatment on the agonist~stimulated 
increase in the accumulation of cyclic AMP (Belmaker, 
1981; Ebstein et al., 1988) and inositol phosphates 
(Casebolt and Jope, 1989; Ebstein et al., 1988; Elphick 
et al., 1988; Godfrey et ai., 1989; Kendall and Nahor-
s.k!, 1987) may be involved in lithium's antimanic and 
prophylactic properties. CBZ iru'libits the accumulation 
of cyclic AMP in brain slices stimulai.ed by noradrena· 
line, ouabain and adenosine (Lewin and Bleck, 1977; 
Palmer et al., 1979; Skerritt et al., 1983a; Weir et al., 
1984), although only at high concentrations. CBZ's ef-
fects on the agonist-evoked formation of inositol phos-
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phates are controversial (Elphick et al., 1988: MeDer-
matt and Logan, 1989). 
In addition to these possible direct effects on second 
messenger generation, CBZ might also interfere with the 
potent synergistic interactions of adenosine with vari.:>us 
neurotransmitters in the regulation of both cyclic AMP 
and inositol phosphate formation (EI-Etr et al., 1989; 
Hili and Kendall, 1987; Hol1ingsworth et al., 1986). The 
blockade by CBZ of A1- and possibly also A2b-recep-
tors should inhibi t these synergistic effects of adenosine 
and could t"ereby profoundly alter the regulation by 
various neurotransmitters of both second messenger 
systems. Thus, Iithium ions and carbamazepine might, 
via different mechanisms, both elicit a dampening effect 
on second messenger generation that could be im-
portant for their similar profile of clinical efficacy in 
affective psychoses. 
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